FIELD: medicine; pharmacology.
SUBSTANCE: injection dosage form for acute stroke treatment includes noopeot in therapeutically effective amount as reactant, and as adjuvants, at least one selected from group including lactose, saccharose, polyvinyl alcohol, polyvinylpyrrolidone, sorbite, mannitol, glycine, aqueous solutions, fatty oils, ethyl oleate, glycerine, ethyl alcohol, propylene glycol, polyethylene oxide 400, benzyl benzoate, benzyl alcohol and other adjuvants allowed for medical application. Injection dosage form meets all requirements of State Pharmacopeia, XI edition. Medical product Noopept (N-phenyl acetyl-L- prolyl glycine ethyl ether) as injection dosage form provides high nootropic and neuroprotective activity applied to models of extensive ischemic stroke and hemorrhagic stroke.
EFFECT: stabile storage ability and high bioavailability.
8 cl, 1 tbl, 2 ex
| Title | Year | Author | Number |
|---|---|---|---|
| INJECTION DOSAGE FORM FOR TREATING ACUTE ISCHEMIC STROKE AND CRANIOCEREBERAL INJURY, METHOD FOR PREPARING AND USING | 2009 |
|
RU2431496C2 |
| AGENT FOR REDUCTION OF GLUTAMATE-INDUCED APOPTOSIS AND INHIBITION OF NMDA-RECEPTOR, POSSESSING IMMUNOMODULATORY ACTION, FOR TREATING NERVOUS SYSTEM DISORDERS, EFFECTS OF CRANIOCEREBERAL INJURY AND ISCHEMIC AND HEMORRHAGIC STROKE | 2013 |
|
RU2605339C2 |
| SUBSTANCE OF NEUROTROPIC- NEUROREGULATING ACTIVITY | 2006 |
|
RU2329804C2 |
| METHOD OF TREATING ISCHEMIC STROKE | 2013 |
|
RU2554500C2 |
| AGENT FOR TREATMENT OF ACUTE AND CHRONIC DISTURBANCES OF CEREBRAL CIRCULATION, INCLUDING STROKE ON BASIS OF HYDROGENATED PYRIDO (4,3-b)INDOLES (VERSIONS), PHARMACOLOGICAL AGENT ON ITS BASIS AND METHOD OF ITS APPLICATION | 2006 |
|
RU2340342C2 |
| METHOD OF TREATING BODY SYSTEM INVOLVEMENTS CAUSED BY ACTIVATED PEROXIDATION PROCESS AND LIQUID PHARMACEUTICAL COMPOSITION FOR IMPLEMENTATION THEREOF | 2008 |
|
RU2411034C2 |
| INFUSION SOLUTION "BRAVINTON" FOR IMPROVEMENT OF CEREBRAL CIRCULATION | 2001 |
|
RU2212890C2 |
| PHARMACEUTICAL COMPOSITIONS IN LIQUID DOSAGE FORM FOR TREATMENT OF CEREBROVASCULAR DISORDERS AND METHOD FOR PRODUCTION THEREOF | 2015 |
|
RU2582961C1 |
| AGENT HAVING NOOTROPIC EFFECT ON BODY | 2017 |
|
RU2694233C2 |
| DIBENZOFURAN OXIME DERIVANTS WITH ANTICONVULSANT AND NEUROPROTECTIVE ACTIVITY | 2018 |
|
RU2744758C2 |
